Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms. Photys was co-founded by the Broad Institute’s leading bifunctional chemist, Amit Choudhary, and the Longwood Fund, alongside a scientific advisory board comprised of distinguished scientists and drug developers – MIT’s Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, MPM’s Wendy Young, and Dana Farber’s Eric Fischer.
Company Details
- Employees
- 25
- Founded
- -
- Address
- 880 Winter Street, Waltham,ma 02451,united States
- Industry
- Biotechnology
- Website
- https://photys.com
- HQ
- Waltham, MA
Photys Therapeutics Questions
Photys Therapeutics's website is https://photys.com
Photys Therapeutics's LinkedIn profile is https://www.linkedin.com/company/photys
Photys Therapeutics has
25 employees.
View email and phone details for 25
employees at Photys Therapeutics.
Photys Therapeutics's industry is
Biotechnology
Photys Therapeutics's top competitors are
Tessera Therapeutics,
Moma Therapeutics,
Treeline Biosciences,
Odyssey Therapeutics,
Korro Bio, Inc.,
Polymed Biopharmaceuticals,
Delphia Therapeutics,
Bicara Therapeutics,
Nested Therapeutics,
Paq Therapeutics.
Photys Therapeutics's categories are Biotechnology
Photys Therapeutics's founding year is 2021
